Cationic Exosome Surface Modification for Cartilage Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Exosomes struggle to penetrate and effectively target negatively charged tissues like cartilage due to their negatively charged lipid bilayer, which limits their ability to reach chondrocytes in deep cartilage layers and are rapidly cleared from the joint, hindering therapeutic efficacy.
Innovation Solution
Modify exosomes by anchoring cationic peptide carriers and cationic glycoproteins like Avidin to their lipid bilayer, reversing their net charge and enabling electrostatic interactions with negatively charged cartilage, allowing full-thickness penetration and retention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exosomes are used in their native form, then they maintain high biocompatibility and cell-targeting capability, but they cannot penetrate the negatively charged cartilage ECM and are rapidly cleared from the joint
Solution Approach 1:
The patent applies parameter changes by modifying the surface charge of exosomes from negative to positive through conjugation with cationic peptides and proteins. This fundamental parameter change enables the exosomes to overcome electrostatic repulsion from the negatively charged cartilage ECM, allowing penetration and retention while preserving their biocompatibility and targeting capabilities
Solution Approach 2:
The patent creates composite exosome structures by combining native exosome components with exogenous cationic peptides and proteins. This composite approach allows the exosomes to gain positive charge for ECM penetration while retaining the original exosome's biocompatibility, targeting receptors, and therapeutic cargo delivery capability
2Strength
If the density of aggrecan-GAGs increases with depth into cartilage, then cartilage structural integrity is maintained, but diffusion of particles larger than 10 nm is limited to the deep zone
Solution Approach 1:
The patent changes the charge parameter of exosomes to positive, which enables electrostatic attraction to the negatively charged aggrecan-GAGs in the cartilage ECM. This facilitates active targeting and accumulation in the deep zone where chondrocytes are located, overcoming the diffusion barrier created by high GAG density while the structural integrity of cartilage remains preserved
3Ease of operation
If IA administered exosomes are used, then they can reach the joint space, but they suffer from rapid joint clearance and poor biodistribution
Solution Approach 1:
By changing the surface charge parameter from negative to positive, the exosomes exhibit enhanced retention in the joint space. The positive charge enables electrostatic interaction with the negatively charged cartilage ECM, creating anchoring effects that significantly extend joint residence time and improve biodistribution, while maintaining the ease of intra-articular administration
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Cationic exosomes demonstrate enhanced uptake and retention in cartilage, effectively delivering therapeutic agents, including mRNA, to chondrocytes, overcoming the limitations of native exosomes.
Implementation Method 1
the linking moiety is linked to the lipid bilayer via non-covalent interactions
Implementation Method 2
the protein residue or polypeptide residue is covalently linked to the linking moiety
Implementation Method 3
reversing their net charge and enabling electrostatic interactions with negatively charged cartilage
Data Source
AI summary
Disclosed are cationic polypeptide modified exosome complexes, and methods of delivery thereof, and associated methods of treatment.